FIRVANQ
CutisPharma, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87715534 |
| Registration Number | 5651067 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Douglas R. Wolf |
| Attorney Docket Number | C104720024US |
| Law Office Assigned | M80 |
| Employee Name | RYDLAND, STEPHANIE DIA |
Timeline
| 2017-12-11 | Application Filed |
| 2018-04-02 | Date of First Use |
| 2018-04-24 | Published for Opposition |
| 2018-12-03 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-01-08 | Status: Live/Registered |
| 2019-01-08 | Trademark Registered |
| 2019-01-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CutisPharma, Inc. |
| Address | 841 Woburn Street Wilmington DE 01887 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | antibiotics; pharmaceutical preparations, namely, vancomycin for the treatment of colitis and gastrointestinal disorders in oral solution form, powder form and diluent form; pharmaceutical preparations, namely, vancomycin for the treatment of clostridium difficile and staphylococcus aureus colitis in oral solution form, powder form and diluent form |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-12-14 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-12-20 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2017-12-21 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2018-03-22 | 4 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-22 | 5 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-04-04 | 6 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-04-24 | 7 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-04-24 | 8 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-06-19 | 9 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2018-11-06 | 10 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-11-27 | 11 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2018-11-06 | 12 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2018-11-27 | 13 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2018-12-03 | 14 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2018-12-04 | 15 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-01-08 | 16 R.PR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2019-03-26 | 17 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2019-03-26 | 18 CHAN I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2019-05-23 | 19 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2019-05-23 | 20 CHAN I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2020-04-29 | 21 ASGN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2024-01-08 | 22 REM1 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FIRVANQ 87715534 5651067 Live/Registered |
CutisPharma, Inc. 2017-12-11 |
 FIRVANQ 87451656 5525903 Live/Registered |
CutisPharma, Inc. 2017-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 